Synthon-Based Strategies Exploiting Molecular Similarity and Protein-Ligand Interactions for Efficient Screening of Ultra-Large Chemical Libraries
- PMID: 40294889
- PMCID: PMC12309548
- DOI: 10.1021/acs.jcim.5c00222
Synthon-Based Strategies Exploiting Molecular Similarity and Protein-Ligand Interactions for Efficient Screening of Ultra-Large Chemical Libraries
Abstract
The rapid expansion of ultralarge chemical libraries has revolutionized drug discovery, providing access to billions of compounds. However, this growth poses relevant challenges for traditional virtual screening (VS) methods. To address these limitations, synthon-based approaches have emerged as scalable alternatives, exploiting combinatorial chemistry principles to prioritize building blocks over enumerated molecules. In this work, we present exaScreen and exaDock, two novel synthon-based methodologies designed for ligand-based and structure-based VS, respectively. In the former case, synthon selection is guided by the 3D hydrophobic/philic distribution pattern in conjunction with a specific synthon alignment protocol based on a quadrupolar expansion over the atoms that participate in the linking bonds between fragments. On the other hand, accommodation to the binding site under a geometrically restrained docking of synthon-based hybrid compounds is used in the selection of the optimal synthon combinations. These strategies exhibit comparable performance to the search performed using fully enumerated libraries in identifying active compounds with significantly lower computational cost, offering computationally efficient strategies for VS in ultralarge chemical spaces.
Similar articles
-
High-Throughput Virtual Screening of Small Molecule Modulators Against Viral Proteins.Methods Mol Biol. 2025;2952:193-218. doi: 10.1007/978-1-0716-4690-8_11. Methods Mol Biol. 2025. PMID: 40553334
-
Ultrahigh-Throughput Virtual Screening Strategies against PPI Targets: A Case Study of STAT Inhibitors.J Chem Inf Model. 2025 Jul 28;65(14):7734-7748. doi: 10.1021/acs.jcim.5c00907. Epub 2025 Jul 4. J Chem Inf Model. 2025. PMID: 40611790 Free PMC article.
-
An artificial intelligence accelerated virtual screening platform for drug discovery.Nat Commun. 2024 Sep 5;15(1):7761. doi: 10.1038/s41467-024-52061-7. Nat Commun. 2024. PMID: 39237523 Free PMC article.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
[Research progress of peptide recognition-guided strategies for exosome isolation and enrichment].Se Pu. 2025 May;43(5):446-454. doi: 10.3724/SP.J.1123.2024.10015. Se Pu. 2025. PMID: 40331609 Free PMC article. Review. Chinese.
References
-
- Lyu J., Wang S., Balius T. E., Singh I., Levit A., Moroz Y. S., O’Meara M. J., Che T., Algaa E., Tolmachova K., Tolmachev A. A., Shoichet B. K., Roth B. L., Irwin J. J.. Ultra-Large Library Docking for Discovering New Chemotypes. Nature. 2019;566(7743):224–229. doi: 10.1038/s41586-019-0917-9. - DOI - PMC - PubMed
-
- Gorgulla C., Boeszoermenyi A., Wang Z. F., Fischer P. D., Coote P. W., Padmanabha Das K. M., Malets Y. S., Radchenko D. S., Moroz Y. S., Scott D. A., Fackeldey K., Hoffmann M., Iavniuk I., Wagner G., Arthanari H.. An Open-Source Drug Discovery Platform Enables Ultra-Large Virtual Screens. Nature. 2020;580(7805):663–668. doi: 10.1038/s41586-020-2117-z. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources